Stephen A Boorjian Selected Research

Steroids

12/2016	Characterization of perioperative infection risk among patients undergoing radical cystectomy: Results from the national surgical quality improvement program.
2/2016	Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
8/2010	The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen A Boorjian Research Topics

Disease

171	Neoplasms (Cancer) 02/2024 - 12/2005
76	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 12/2005
71	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 08/2007
66	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 10/2005
50	Carcinoma (Carcinomatosis) 01/2024 - 10/2006
39	Neoplasm Metastasis (Metastasis) 10/2023 - 07/2008
21	Disease Progression 10/2023 - 04/2008
13	Non-Muscle Invasive Bladder Neoplasms 03/2022 - 08/2010
9	Margins of Excision 01/2019 - 03/2010
7	Thrombosis (Thrombus) 10/2023 - 08/2007
7	Venous Thromboembolism 01/2023 - 01/2014
7	Hematuria 01/2023 - 01/2012
7	Chronic Renal Insufficiency 11/2022 - 07/2012
6	Angiomyolipoma 07/2023 - 12/2007
6	Hemorrhage 11/2020 - 01/2012
5	Lymphatic Metastasis 09/2023 - 09/2007
5	Kidney Neoplasms (Kidney Cancer) 06/2019 - 07/2010
4	Lymphadenopathy 10/2023 - 01/2017
4	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 10/2008
4	Necrosis 01/2021 - 10/2014
4	Pathologic Constriction (Stenosis) 02/2020 - 12/2010
4	Sarcopenia 01/2019 - 09/2014
4	Hemorrhagic Cystitis 03/2017 - 12/2014
3	Adenocarcinoma 02/2024 - 09/2009
3	Hypertension (High Blood Pressure) 11/2022 - 10/2016
3	Venous Thrombosis (Deep-Vein Thrombosis) 09/2021 - 06/2012
3	Hypothermia 01/2021 - 09/2009
3	Hydronephrosis 01/2021 - 01/2011
3	Neuroendocrine Carcinoma 01/2019 - 10/2015
3	Residual Neoplasm 03/2018 - 11/2017
3	Solitary Kidney 01/2018 - 02/2011
2	Seminoma 10/2023 - 01/2023
2	Mesothelioma 10/2022 - 11/2021
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2022 - 03/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 03/2020
2	Anemia 11/2020 - 10/2016
2	Infections 01/2020 - 12/2016
2	Lymphocele 01/2020 - 11/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 08/2013
2	Obesity 05/2015 - 07/2008
2	Extranodal Extension 03/2015 - 01/2014
2	Ischemia 11/2011 - 02/2011

Drug/Important Bio-Agent (IBA)

26	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 09/2007
15	AndrogensIBA 01/2023 - 05/2008
8	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 08/2008
6	Dihydrotachysterol (AT 10)IBA 11/2020 - 09/2011
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2005
5	Hormones (Hormone)IBA 01/2020 - 10/2008
4	GenieIBA 07/2023 - 01/2021
4	pembrolizumabIBA 01/2023 - 10/2017
4	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2019
3	AntibodiesIBA 01/2022 - 12/2005
3	Kallikreins (Kallikrein)IBA 11/2021 - 01/2020
3	SteroidsIBA 12/2016 - 08/2010
3	Androgen Receptors (Androgen Receptor)IBA 02/2015 - 03/2009
3	Messenger RNA (mRNA)IBA 12/2013 - 12/2005
2	Vinblastine (Vinblastine Sulfate)FDA Link 12/2022 - 06/2014
2	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 06/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 06/2014
2	Gemcitabine FDA Link 12/2022 - 05/2021
2	Choline (Choline Chloride)IBA 12/2022 - 01/2017
2	PlatinumIBA 01/2022 - 08/2017
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	trans-sodium crocetinate (crocetin)IBA 01/2022 - 01/2021
2	Docetaxel (Taxotere)FDA Link 05/2021 - 01/2018
2	ParaffinIBA 01/2021 - 12/2009
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2020
2	SurvivinIBA 01/2021 - 08/2008
2	Metformin (Glucophage)FDA LinkGeneric 11/2018 - 02/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 09/2015
2	Alkaline PhosphataseIBA 09/2015 - 10/2014

Therapy/Procedure

103	Cystectomy 03/2024 - 08/2008
81	Nephrectomy 10/2023 - 08/2007
61	Therapeutics 02/2024 - 10/2005
51	Prostatectomy (Retropubic Prostatectomy) 02/2024 - 10/2005
25	Neoadjuvant Therapy 03/2024 - 01/2011
23	Radiotherapy 03/2024 - 12/2009
18	Cryosurgery 10/2023 - 01/2012
15	Lymph Node Excision (Lymph Node Dissection) 10/2023 - 03/2014
13	Drug Therapy (Chemotherapy) 03/2024 - 01/2011
10	Nephroureterectomy 02/2023 - 10/2006
10	Blood Transfusion (Blood Transfusions) 01/2023 - 05/2013
9	Urinary Diversion (Ileal Conduit) 11/2023 - 12/2008
7	Length of Stay 11/2023 - 10/2006
7	Metastasectomy 10/2023 - 07/2011
6	Salvage Therapy 02/2024 - 03/2010
6	Stents 11/2023 - 12/2010
6	Aftercare (After-Treatment) 01/2023 - 02/2013
6	Thrombectomy 05/2018 - 08/2007
6	Adjuvant Chemotherapy 07/2017 - 12/2013
5	Operative Time 01/2023 - 10/2006
4	Castration 01/2023 - 09/2012
4	Combined Modality Therapy 08/2014 - 09/2009
2	Immunotherapy 01/2023 - 07/2010
2	Orchiectomy (Orchidectomy) 01/2022 - 01/2017
2	Nephrotomy 01/2021 - 01/2016
2	Kidney Transplantation 03/2020 - 01/2019
2	Adjuvant Radiotherapy 11/2017 - 01/2016
2	Radiofrequency Ablation 06/2015 - 04/2014